Porras M, Martín M T, Torres R, Vergara P
Edificio V, Unidad de Fisiología, Universidad Autónoma de Barcelona, 08193 Bellaterra, Spain.
Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G423-30. doi: 10.1152/ajpgi.00323.2005. Epub 2005 Oct 20.
We previously reported that indomethacin induces a chronic intestinal inflammation in the rat where the cyclical characteristic phases of Crohn's disease are manifested with a few days' interval and lasting for several months: active phase (high inflammation, hypomotility, bacterial translocation) and reactive phase (low inflammation, hypermotility, no bacterial translocation). In this study, we investigated the possible role of both constitutive and inducible isoforms of nitric oxide (NO) synthase (NOS) and cyclooxygenase (COX) in the cyclicity of active and reactive phases in rats with chronic intestinal inflammation. Rats selected at either active or reactive phases and from 2 to 60 days after indomethacin treatment were used. mRNA expression of both constitutive and inducible NOS and COX isoforms in each phase was evaluated by RT-PCR and cellular enzyme localization by immunohistochemistry. The effects of different COX and NOS inhibitors on the intestinal motor activity were tested. mRNA expression of COX-1 was not modified by inflammation, whereas mRNA expression of neuronal NOS was reduced in all indomethacin-treated rats. In contrast, NOS and COX inducible forms showed a cyclical oscillation. mRNA expression and protein of both iNOS and COX-2 increased only during active phases. The intestinal hypomotility associated with active phases was turned into hypermotility after the administration of selective iNOS inhibitors. Sustained downregulation of constitutive NOS caused hypermotility, possibly as a defense mechanism. However, this reaction was masked during the active phases due to the inhibitory effects of NO resulting from the increased levels of the inducible NOS isoform.
我们之前报道过,吲哚美辛可在大鼠中诱发慢性肠道炎症,克罗恩病的周期性特征阶段会间隔几天出现,并持续数月:活动期(高度炎症、运动减弱、细菌移位)和反应期(低度炎症、运动亢进、无细菌移位)。在本研究中,我们调查了一氧化氮(NO)合酶(NOS)和环氧化酶(COX)的组成型和诱导型同工型在慢性肠道炎症大鼠活动期和反应期的周期性变化中可能发挥的作用。选用了在吲哚美辛治疗后2至60天处于活动期或反应期的大鼠。通过逆转录聚合酶链反应(RT-PCR)评估各阶段组成型和诱导型NOS及COX同工型的mRNA表达,并通过免疫组织化学进行细胞酶定位。测试了不同COX和NOS抑制剂对肠道运动活性的影响。COX-1的mRNA表达不受炎症影响,而在所有吲哚美辛治疗的大鼠中,神经元型NOS的mRNA表达均降低。相反,NOS和COX的诱导型表现出周期性振荡。诱导型一氧化氮合酶(iNOS)和COX-2的mRNA表达及蛋白仅在活动期增加。给予选择性iNOS抑制剂后,与活动期相关的肠道运动减弱转变为运动亢进。组成型NOS的持续下调导致运动亢进,这可能是一种防御机制。然而,由于诱导型NOS同工型水平升高产生的NO的抑制作用,这种反应在活动期被掩盖。